Clinical Outcomes

Long-term results you can trust

U.S. Pivotal Clinical Trials: Five year data across ALL etiologies.

U.S. IDE Clinical Trials: Five year data across ALL etiologies.

Download brochure

Real-world data

SURPASS† Registry results

Graphic with real world data

Download flyer

GREAT data highlights through three years1 across ALL etiologies

GREAT Registry Results graphic

Download TBAD results

video thumbnail

5-year Outcomes: U.S. IDE Clinical Trial, Traumatic Aortic Transection

Mark Farber, M.D., National Principal Investigator provides his perspective on key study outcomes

View video (3:44)

Time-tested innovation

time-tested innovation graphic

View all thoracic firsts

* Migrations are reported as those requiring reintervention.

† Rates are based on physician experience as reported for 127 subjects in Europe within a 30 day follow-up period. European-Post Approval Registry: Observational Registry Characterizing the Performance and Feature Use of the GORE® TAG® Conformable Thoracic Stent Graft Featuring ACTIVE CONTROL System. (data on file 2017; W.L. Gore & Associates, Inc; Flagstaff, AZ.)

‡ Note: Only serious endoleaks are reported in GREAT (i.e., requiring reintervention).

§ Data on file; W.L. Gore & Associates, Inc.; Flagstaff, AZ.

  1. W. L. Gore & Associates. 'GREAT' Global Registry for Endovascular Aortic Treatment - Outcomes Evaluation. Bethesda, MD: National Library of Medicine; 2012. Available from: NLM Identifier: NCT01658787. Published August 7, 2012. Updated: September 29, 2021. Accessed June 7, 2022. https://clinicaltrials.gov/ct2/show/NCT01658787

eIFU Symbol

Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for markets where this product is available. RXOnly

Related to this product

231157293-EN

Residents of some states have the right to opt-out of the “sharing” or “selling” of their personal information. Gore does not "sell" the personal information of website users. Gore may "share" the personal information of website users, as standard advertising practice meant to offer you a more personalized service.

If you want to opt-out from Gore “sharing” your personal information, click on Opt-Out of Sharing to turn off the targeting cookies that we share with our advertising partners in order to provide you with personalized information. Disabling sharing will stop the use of cookies to targeted advertising but you may still see generic Gore ads.

Please note that your exercising of the rights outlined will have no adverse effect on the price and quality of our goods or services.

Opt-Out of Sharing

You Have Successfully Opted Out of the Sharing of Your Personal Information

Please note that if you clear your cookies and then use another device or browser, etc. your opt-out status is not transferred to the new device or browser.